PH31589A - Amide derivatives as 5-ht1a ligands. - Google Patents
Amide derivatives as 5-ht1a ligands.Info
- Publication number
- PH31589A PH31589A PH47940A PH47940A PH31589A PH 31589 A PH31589 A PH 31589A PH 47940 A PH47940 A PH 47940A PH 47940 A PH47940 A PH 47940A PH 31589 A PH31589 A PH 31589A
- Authority
- PH
- Philippines
- Prior art keywords
- pct
- date
- amide derivatives
- sec
- formula
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 229940005530 anxiolytics Drugs 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939305672A GB9305672D0 (en) | 1993-03-19 | 1993-03-19 | Amide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
PH31589A true PH31589A (en) | 1998-11-03 |
Family
ID=10732342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH47940A PH31589A (en) | 1993-03-19 | 1994-03-17 | Amide derivatives as 5-ht1a ligands. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5629323A (ja) |
EP (1) | EP0689534B1 (ja) |
JP (1) | JPH08507779A (ja) |
AT (1) | ATE225335T1 (ja) |
AU (1) | AU6149094A (ja) |
DE (1) | DE69431471T2 (ja) |
DK (1) | DK0689534T3 (ja) |
ES (1) | ES2181711T3 (ja) |
GB (1) | GB9305672D0 (ja) |
PH (1) | PH31589A (ja) |
PT (1) | PT689534E (ja) |
WO (1) | WO1994021611A1 (ja) |
ZA (1) | ZA941739B (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541179A (en) * | 1995-05-02 | 1996-07-30 | American Home Products Corporation | Tropon-2-one piperazine carboxamides as serotonergic agents |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
US6906069B1 (en) | 1999-01-08 | 2005-06-14 | Amgen Inc. | LXR modulators |
DK1394150T3 (da) | 1999-02-24 | 2011-03-21 | Hoffmann La Roche | 4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister |
AU2000235960A1 (en) * | 2000-02-14 | 2001-08-27 | Tularik, Inc. | Lxr modulators |
US6673543B2 (en) | 2000-04-05 | 2004-01-06 | Tularik, Inc. | Solid phase synthesis of LXR ligands |
CA2474702A1 (en) | 2002-01-30 | 2003-08-07 | Tularik Inc | Heterocyclic arylsulfonamidobenzylic compounds |
TWI280239B (en) | 2003-07-15 | 2007-05-01 | Hoffmann La Roche | Process for preparation of pyridine derivatives |
ES2335922T3 (es) | 2005-09-23 | 2010-04-06 | F.Hoffmann-La Roche Ag | Nueva formulacion de dosificacion. |
US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1244418A (en) * | 1984-07-30 | 1988-11-08 | Marcel Hibert | Glutarimide antianxiety and antihypertensive agents |
JPH02138181A (ja) * | 1988-11-08 | 1990-05-28 | Ist Luso Farmaco Italia Spa | 血圧降下活生を有する2,2‐ジ置換2,3‐ジヒドロ‐1,4ベンゾジオキシン誘導体 |
GB9021535D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
-
1993
- 1993-03-19 GB GB939305672A patent/GB9305672D0/en active Pending
-
1994
- 1994-03-09 AT AT94908456T patent/ATE225335T1/de not_active IP Right Cessation
- 1994-03-09 DE DE69431471T patent/DE69431471T2/de not_active Expired - Fee Related
- 1994-03-09 JP JP6520749A patent/JPH08507779A/ja not_active Withdrawn
- 1994-03-09 US US08/446,651 patent/US5629323A/en not_active Expired - Lifetime
- 1994-03-09 PT PT94908456T patent/PT689534E/pt unknown
- 1994-03-09 WO PCT/GB1994/000455 patent/WO1994021611A1/en active IP Right Grant
- 1994-03-09 AU AU61490/94A patent/AU6149094A/en not_active Abandoned
- 1994-03-09 DK DK94908456T patent/DK0689534T3/da active
- 1994-03-09 ES ES94908456T patent/ES2181711T3/es not_active Expired - Lifetime
- 1994-03-09 EP EP94908456A patent/EP0689534B1/en not_active Expired - Lifetime
- 1994-03-11 ZA ZA941739A patent/ZA941739B/xx unknown
- 1994-03-17 PH PH47940A patent/PH31589A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH08507779A (ja) | 1996-08-20 |
GB9305672D0 (en) | 1993-05-05 |
PT689534E (pt) | 2003-01-31 |
US5629323A (en) | 1997-05-13 |
WO1994021611A1 (en) | 1994-09-29 |
ATE225335T1 (de) | 2002-10-15 |
ES2181711T3 (es) | 2003-03-01 |
DE69431471D1 (de) | 2002-11-07 |
ZA941739B (en) | 1995-09-11 |
AU6149094A (en) | 1994-10-11 |
EP0689534B1 (en) | 2002-10-02 |
DK0689534T3 (da) | 2003-02-03 |
DE69431471T2 (de) | 2003-07-10 |
EP0689534A1 (en) | 1996-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9300194D0 (en) | Piperazine derivatives | |
HUT60464A (en) | Process for producing n-phenylbenzamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
AU1070895A (en) | Indole-derived arylpiperazines as ligands for 5HT1-like receptors 5HT1B and 5HT1D | |
MY109337A (en) | Phenoxyl-and phenoxyalkyl-piperidines as antiviral agents | |
PH31589A (en) | Amide derivatives as 5-ht1a ligands. | |
GB9314758D0 (en) | Heterocyclic derivatives | |
PH31303A (en) | Piperazine derivatives. | |
TW281673B (ja) | ||
DE59304311D1 (de) | N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika | |
AU6991696A (en) | 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents | |
GB9221931D0 (en) | Piperazine derivatives | |
TW282458B (ja) | ||
NZ291855A (en) | Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists | |
HU9500710D0 (en) | Ureido-acetamide derivatives, preparation thereof and drugs containing same |